Summary
Dr Vasileios Panoulas is a Consultant Interventional Cardiologist at the Royal Brompton and Harefield hospitals, part of the Guys and St Thomas NHS Foundation Trust and Honorary Senior Clinical Lecturer at Imperial College London.
He has clinical expertise that encompasses both general and interventional cardiology. He is a high volume PCI and TAVI (trans catheter aortic valve implantation) operator with interest in complex high risk PCI and use of mechanical circulatory support (MCS) in patients with cardiogenic shock.
Dr Panoulas' research interests involve clinical outcomes with new generation TAVI devices, use of MCS in patients presenting with cardiogenic shock, management of acute coronary syndromes (ACS) and hypertension. Other interests include speckle tracking and hand-held echocardiography and cardiovascular disease in patients with rheumatoid arthritis.
Publications
Journals
Vandenbriele C, M'Pembele R, Dannenberg L, et al. , 2024, Heparin dosing in patients with Impella-supported cardiogenic shock., Int J Cardiol, Vol:399
Ryan M, Ezad SM, Webb I, et al. , 2024, Percutaneous Left Ventricular Unloading During High-Risk Coronary Intervention: Rationale and Design of the CHIP-BCIS3 Randomized Controlled Trial., Circ Cardiovasc Interv, Vol:17
Iannaccone M, Barbero U, Franchin L, et al. , 2024, Comparison of mid-term mortality after surgical, supported or unsupported percutaneous revascularization in patients with severely reduced ejection fraction: A direct and network meta-analysis of adjusted observational studies and randomized-controlled., Int J Cardiol, Vol:396
Panoulas VF, Escaned J, Hill JM, et al. , 2024, Predictors of left ventricular ejection fraction in high-risk percutaneous coronary interventions, Frontiers in Cardiovascular Medicine, Vol:11
Tindale A, Panoulas V, 2024, Validation of the BALLAR score for predicting 30-day mortality in patients requiring left-sided Impella support., Cardiovasc Revasc Med, Vol:58, Pages:98-100